Liver transplantation in acute liver failure

Panminerva Medica

Volumn 45, Issue 2, 2003, Pages 85-94

  Higgins, P D R ^a   Fontana, R J ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Brain edema; Hepatitis; Liver failure, acute, diagnosis; Liver transplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; LACTIC ACID;

BLOOD CLOTTING DISORDER; BRAIN EDEMA; DISEASE COURSE; EXTRACORPOREAL CIRCULATION; GRAFT REJECTION; HUMAN; INFECTION COMPLICATION; INFECTION PREVENTION; INTRACRANIAL PRESSURE; LACTATE BLOOD LEVEL; LIVER BIOPSY; LIVER FAILURE; LIVER GRAFT; PATIENT MONITORING; PREDICTION; PROGNOSIS; REVIEW; SURVIVAL RATE; ACUTE DISEASE; ARTIFICIAL LIVER; LIVER; LIVER TRANSPLANTATION; PATHOPHYSIOLOGY;

ACUTE DISEASE; HUMANS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; PROGNOSIS;

EID: 0141484431     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, editors. Progress in liver diseases. New York: Grune & Stratton; 1970.p.282-98.
2. Ellis AJ, Saleh M, Smith H, Portmann B, Gimson A, Williams R. Late-onset hepatic failure: clinical features, serology and outcome following transplantation. J Hepatol 1995;23:363-72.
3. Hoofnagle JH, Carithers RI, Shapiro C, Ascher N. Fulminant hepatic failure: a summary of a workshop. Hepatology 1995;1:240-52.
4. Ostapowicz G, Lee WM. Acute hepatic failure: a western perspective. J Gastroenterol Hepatol 2000;15:480-8.
5. Acharya S, Panda S, Saxena A, Gupta SD. Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol 2000;15:473-9.
6. Fontana RJ, Quallich LG. Acute liver failure. Curr Opin Gastroenterol 2001;17:291-8.
7. Ziv B, Samuel D, Zemel R, Baruch Y, Gigou M, Dikuler E et al. Fulminant nonA-G viral hepatitis leading to liver transplantation. Arch Intern Med 2000;160:388-92.
8. Teo EK, Ostapowicz G, Hussain M, Lee WM, Fontana RJ, Lok ASF. Hepatitis B infection in patients with acute liver failure in the United States. Hepatology 2001;33:972-6.
9. Shibata M, Wang RY, Yoshiba M, Shih JW, Alter HJ, Mitamura K. The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan. J Infect Diseases 2001;184:400-4.
10. Favreau JT, Ryu ML, Braunstein G, Orshansky G, Park SS, Coody GL et al. Severe hepatotoxicity associated with the dietary supplement Lipokinetix. Ann Intern Med 2002;136(8):590-5.
11. Larrey D. Hepatotoxicity of herbal remedies. J Hepatol 1997;26:47-51.
12. Palmer ME, Haller C, McKinney PE, Tschirgi A, Smolinske SC, Woolf A et al. Adverse events associated with dietary supplements. An observational study. Lancet 2003;361:101-6.
13. Seeff LB, Lindsay KL, Bacon BR, Kresina TF, Hoofnagle JH. Complementary and alternative medicine in chronic liver disease. Hepatology 2001;34:595-603.
14. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transplant Surg 1999;5:29-34.
15. Ostapowicz G, Fontana R, Navarro V, Chung RT, Torres MB, Atillasoy E et al. Use of liver transplantation in patients with acute liver failure [abstract]. Hepatology 2000;32:215A.
16. Larson AM, Ostapowicz G, Fontana RJ, Shakil AO, Lee WM. Outcome of acetaminophen induced liver failure in the USA in suicidal versus accidental overdose: preliminary results of a prospective, multi-center trial [abstract]. Hepatology 2000;32:396A.
17. Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995;109:1907-16.
18. Zimmerman HY, Maddrey WC. Acetaminophen hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 1995;22:767-73.
19. Quallich LG, Brown JW, Shehab TM, Fontana RJ. Management of acetaminophen hepatotoxicity: A survey of practicing physicians. J Clin Outcomes Manag 2001;8:25-32.
20. Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997;337:1112-7.
21. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-5.
22. Harrison P, Wendon J, Williams R. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology 1996;23:1067-72.
23. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GM et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective, controlled trial. BMJ 1991;303: 1026-9.
24. Donaldson BW, Gopinath R, Wanless IR, Phillips MJ, Cameron R, Roberts EA et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology 1993;18:1370-4.
25. Hanau C, Munoz SJ, Rubin R. Histopathological heterogeneity in fulminant hepatic failure. Hepatology 1995;21:345-51.
26. Blei A, Larsen F. Pathophysiology of cerebral edema in fulminant hepatic failure. J Hepatol 1999;31:771-6.
27. Larsen FS, Hansen BA, Pott F, Ejlersen E, Secher NH, Paulson OB et al. Dissociated cerebral vasoparalysis in acute liver failure. J Hepatol 1996;25:145-51.
28. Cordoba J, Blei AT. Cerebral edema and intracranial pressure monitoring. Liver Transplant Surg 1995;1:187-94.
29. Munoz SJ, Robinson M, Northrup B, Bell R, Moritiz M, Jarrell B et al. Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology 1991;13:209-12.
30. Wijdicks EFM, Plevak DJ, Rakela J, Wiesner RH. Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc 1995;70:119-24.
31. Larsen FS, Strauss G, Knudsen GM, Heerzog TM, Hansen BA, Secher NH. Cerebral perfusion, cardiac output, and arterial pressure in patients with fulminant hepatic failure. Crit Care Med 2000;28:996-1000.
32. Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology 1992;16:1-7.
33. Detry O, Arkadopoulos N, Ting P, Kahaku E, Margulies J, Arnaout W et al. Intracranial pressure during liver transplantation for fulminant hepatic failure. Transplantation 1999;67:767-70.
34. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999;29:648-53.
35. Jalan R, Damink S, Detuz N, Lee A, Hayes PC. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999;354:1164-8.
36. Jalan R, Olde Damink SWM, Deutz NEP, Hayes PC, Lee A. Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia. Hepatology 2001;34:50-4.
37. Ellis A, Wendon J, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 2000;32:536-41.
38. Clemmesen JO, Hansen BA, Larsen FS. Indomethacin normalizes intracranial pressure in acute liver failure: a 23 year-old-woman treated with indomethacin. Hepatology 1997;26:1423-5.
39. Tofteng F, Jorgensen L, Wang LP, Larsen FS. Indomethacin reduces high intracranial pressure without affecting glutamate and lactate metabolism in patients with fulminant hepatic failure: A cerebral microdialysis study [abstract]. Hepatology 2001;34:253A.
40. Blei AT, Olafsson S, Webseter S, Levy R. Complications of intracranial pressure monitoring in acute liver failure. Lancet 1993;341: 157-8.
41. Bernstein DE, Jeffers L, Erhadtsen E, Reddy KR, Glazer S, Squiban P et al. Recombinant Factor Vila corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology 1997;113: 193-37.
42. Shami VM, Mack BG, Hespenheide EE, Arseneau KO, Bickston SJ, Caldwell SH. Recombinant activated factor VII is superior to plasma alone in correcting the coagulopathy of fulminant hepatic failure [abstract]. Hepatology 2001;34:255A.
43. Hendriks HGD, Meijer K, DeWolf JT, Klompmaker IJ, Porte RJ, Kam PJ et al. Reduced transfusion requirements by recombinant factor Vila in orthotopic liver transplantation. Transplantation 2001;71: 402-5.
44. Kalcinski P, Kaminiski A, Drewniak T, Ismail H, Szymczak M, Markiewicz M et al. Quick correction of hemostasis in 2 patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII. Transplant Proc 1999;31:378-9.
45. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990;11:49-53.
46. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Casewell M et al. Fungal infection: a common, unrecognized complication of acute liver failure. J Hepatol 1991;12:1-9.
47. Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infections in acute liver failure. Semin Liver Dis 1996;16:389-402.
48. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000;32:734-9.
49. Rolando N, Gimson AES, Wade JJ, Philpott-Howard J, Casewell M, Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993;17:196-201.
50. Rolando N, Wade JJ, Stangou A, Gimson AE, Wendon J, Philpott-Howard J et al. Prospective study comparing propylactic parenteral antimicrobials with or without enteral decontamination in patients with acute liver failure. Liver Transplant 1996;2:8-13.
51. Papanicolaou GA, Meyers BR, Meyers J, Mendelson MH, Lou W, Emre S et al. Nosocomial infections with vancomycin-resistant enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996;23:760-6.
52. Patel R, Badley AD, Larson-KellerJ, Harmsen WS, Ilstrup DM, Wiesner RH et al. Relevance and risk factors of enterococcal bacteremia following liver transplantation. Transplantation 1996;61:1192-7.
53. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-45.
54. Pauwels A, Mostefa-Kara N, Florent C, Levy VG. Emergency liver transplantation for acute liver failure: evaluation of London and Clichy criteria. J Hepatol 1993;17:124-7.
55. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transplant 2000;6:163-9.
56. Dhiman RK, Seth DM, Jain DM, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci 1998;43:1311-6.
57. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: A cohort study. Lancet 2002;359:558-63.
58. Brems JJ, Hiatt JR, Ramming KD, Quinones-Baldrich WJ, Busuttil RW. Fulminant hepatic failure: the role of liver transplantation as primary therapy. Am J Surg 1987;154(1):137-41.
59. Schafer DF, Shaw BW. Fulminant hepatic failure and orthotopic liver transplantation. Semin Liver Dis 1989;9:189-94.
60. Iwatsuki S, Steiber AC, Marsh HW, Tzakis AG, Todo S, Koneru B et al. Liver transplantation for fulminant hepatic failure. Transplant Proc 1989;21:2431-4.
61. Rakela J, Perkins JD, Gross JB, Hayes DH, Plevak DJ, Krom RA et al. Acute hepatic failure: the emerging role of orthotopic liver tranplantation. Mayo Clin Proc 1989;64:424-8.
62. Emond JC, Aran PP, Whitington PF, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989;96:1583-9.
63. Campbell DA, Ham JM, McCurry KR. Liver transplant for fulminant hepatic failure. Am Surg 1991;57:546-9.
64. Alsina AE, Hull D, Bartus SA, Schweizer RT. Liver transplantation for acute fulminant hepatic failure. Conn Med 1992;56:235-9.
65. Munoz SJ, Moritz MJ, Martin P, Jarrell BE, Maddrey WC. Liver transplantation for fulminant hepatic failure. Transplant Proc 1993;25:1773-5.
66. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation for fulminant hepatic failure. Arch Surg 1993;128:677-82.
67. McCashland TM, Shaw BW, Tape E. The American experience with transplantation for acute liver failure. Semin Liver Dis 1996;16:427-33.
68. Devlin J, Wendon J, Heaton N, Tan K, Williams R. Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatology 1995;21:1018-24.
69. Annual report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network-Transplant Data: 1988-2000. UNOS, Richmond, VA, and the Division of Transplantation, Bureau of Health Resources and Services Administration, US Department of Health and Human Services, Rockville, MD, 2000.
70. Marcos A, Ham JM, Fisher RA, Olzinski AT, Posner MP. Single center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transplant 2000;6:296-310.
71. Miwa S, Hasikura Y, Mita A, Kubota T, Chisuwa H, Nakazawa Y. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology 1999;30:1521-6.
72. Liu CL, Fan ST, Lo M, Yong H, Fung ASM, Wong J. Right lobe live donor liver transplantation improves survival of patients with acute liver failure. Br J Surg 2002;89:317-22.
73. Shiffman ML, Brown RRS, Olthoff KM, Everson G, Miller C, Siegler M et al. Living donor liver transplantation: summary of a conference at the National Institutes of Health. Liver Transplant 2002;8:174-89.
74. Adams PC, Ghent CN, Grant DR, Wall WJ. Employment after liver transplantation. Hepatology 1995;21:140-4.
75. Iwatsuki S, Stieber AC, Marsh JW, Tzakis AG, Todo S, Konero B et al. Liver transplantation for fulminant hepatic failure. Transplant Proc 1989;21:2431-4.
76. Bismuth H, Samuel D, Castain D, Adam R, Saliba F, Johann M et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. Ann Surg 1995;222:109-19.
77. Devlin J, Williams R. Transplantation for fulminant hepatic failure. Transplantation 1996;62:151-5.
78. Mohamed R, Hubscher SG, Mirza DF, Gunson BK, Mutimer DJ. Post-transplantation chronic hepatitis in fulminant hepatic failure. Hepatology 1997;25:1003-7.
79. Hubscher SG. Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors and outcome. Liver Transplant 2001;7(4):285-91.
80. Shaw BW. Auxilliary liver transplantation for acute liver failure. Liver Transplant Surg 1995;1:194-201.
81. Van Hoek B, DeBoer J, Boudjema K, Williams R, Corsmit O, Terpstra OT et al. Auxilliary versus orthotopic liver transplantation for acute liver failure. J Hepatol 1999;30:699-705.
82. Srinivisan P, Jassem W, Melendex HV, Mieili-Vergani G, O'Grady J, Muiesan P et al. Long term prospects for immunosuppresion withdrawal after successful auxiliary transplantation for acute liver failure [abstract]. Hepatology 2001;34:246A.
83. Samuel D, Ichai P, Castaing D, Saliba F, Adam R, Savier E et al. Auxiliary partial orthotopic vs standard orthotopic whole liver transplantation for acute liver failure: a reappraisal from a single center by a case-control study [abstract]. Hepatology 2001;34:241A.
84. Allen JW, Hassanein T, Bhatia SN. Advances in bioartificial liver devices. Hepatology 2001;34:447-55.
85. Ellis AJ, Hughers RD, Wendon JA, Dunne J, Langley PG, Kelly JH et al. Pilot controlled trial of extracorporeal liver assist device in acute liver failure. Hepatology 1996;24:1446-51.
86. Watanabe FD, Mullon CJ, Hewitt WR, Arkadopoulos N, Kahaku E, Eguchi S et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg 1997;225:484-91.
87. Stevens AC, Busuttil R, Han S, Baquerizo A, Fair J, Shrestha R et al. An interim analysis of a phase II/III prospective, randomized multicenter, controlled tirai of the Hepat Assist bioartificial liver support system for the treatment of acute liver failure [abstract]. Hepatology 2001;34:509A.
88. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transplant 2000;6:277-86.
89. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane based blood purification system for bioartificial liver support. Artif Org 1999;23:319-30.
90. Novelli G, Rossi M, Pretagostini R, Poli L, Peritore D, Berloco P et al Use of MARS in the treatment of acute liver failure: preliminary monocentric experience. Transplant Proc 2001;33:1942-4.
91. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1986;94:1186-92.
92. Tsarev SA, Tsareva TS, Emerson SU, Govindarajan S, Shapiro M, Gerin JL et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 1997;15:1834-8.
93. Hawton K, Ware C, Mistry H, Hewitt J, Kingsbury S, Roberts D et al. Paracetamol self-poisoning: characteristics, prevention, and harm reduction. Br J Psychiatry 1996;168:43-8.
94. Chan TY. Safety packaging of acetaminophen combination prep-arations and severity of adult poisoning. J Clin Tox 1996;34: 747-9.
95. Hawton K, Townsend E, Deeks J, Appleby L, Gunnell D, Bennewith O et al. Effects of legislation restricting pack sizes of paracetamol and salicylate on self-poisoning in the United Kingdom: before and after study. BMJ 2001;322:1203-7.
96. Turvill JL, Burroughts AK, Moore KP. Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet 2000;355:2048-9.
97. Watkins PB, Whitcomb W. Hepatic dysfunction associated with troglitazone. N Engl J Med 1998;338:916-7.
98. Murphy EJ, Davern TJ, Shakil AO, Shick L, Masharani U, Chow H et al. Troglitazone-induced hepatic failure. Dig Dis Sci 2000;45: 549-53.
99. Fontana RJ, McCashland TM, Benner KG, Appelman HD, Gunartanam NT, Wisecarver JL et al. Acute liver failure associated with prolonged use of bromfenac leading to the liver transplantation. Liver Transplant Surg 1999;5:480-4.
100. Nightingale S. From the food and drug administration: Trovofloxacin public health advisory. JAMA 1999;282:19.